DOW JONES25,409.36-357.28 -1.39%
S&P 5002,954.22-24.54 -0.82%
NASDAQ8,567.37+0.89 0.01%

BTIG Initiates Coverage On Cue Biopharma with Buy Rating, Announces $26 Price Target

BTIG initiates coverage on Cue Biopharma (NASDAQ:CUE) with a Buy rating and a $26 price target.

Benzinga · 01/28/2020 12:33

BTIG initiates coverage on Cue Biopharma (NASDAQ:CUE) with a Buy rating and a $26 price target.